Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LLY | Common Stock | Options Exercise | $0 | +3.62K | +30.54% | $0.00 | 15.5K | Feb 1, 2024 | Direct | |
transaction | LLY | Common Stock | Tax liability | -$1.09M | -1.69K | -10.9% | $645.61 | 13.8K | Feb 1, 2024 | Direct | |
holding | LLY | Common Stock | 4.34K | Feb 1, 2024 | Van Naarden Family Trust | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LLY | Restricted Stock Unit | Options Exercise | $0 | -3.62K | -100% | $0.00* | 0 | Feb 1, 2024 | Common Stock | 3.62K | Direct | F2 |
Id | Content |
---|---|
F1 | The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose. |
F2 | Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |